Skip to main content Skip to search

YU News

YU News

William Jacobs Makes Important TB Discovery, Will Lead International TB-HIV Research Institute

Researchers from Albert Einstein College of Medicine and the University of Pittsburgh have developed an onsite method to quickly diagnose tuberculosis (TB) and expose the deadly drug-resistant strains that can mingle undetected with treatable TB strains. This study will be published in "PLoS ONE," a peer-reviewed online journal from the Public Library of Science. The study was authored by Graham Hatfull, PhD, and William R. Jacobs, Jr., PhD, professor of microbiology and immunology and of genetics. Read more.

The group's research was funded as part of a major new research initiative from the Howard Hughes Medical Institute (HHMI).

HHMI announced on March 19 that it will partner with the University of KwaZulu-Natal in South Africa to establish an international research center focused on the TB and HIV coepidemics, called KwaZulu-Natal Research Institute for TB-HIV (K-RITH). Dr. Jacobs will direct research into developing rapid and effective TB tests, one of the new institute's primary objectives. His work with Hatfull and postdoctoral fellow Mariana Piuri on the flurophage study was related to that effort. Read more about Dr. Jacobs' appointment at the research institute.

Read article featuring Dr. Jacobs' comments on the international research center.